File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1158/0008-5472.CAN-09-3324
- Scopus: eid_2-s2.0-75149132744
- PMID: 19996284
- WOS: WOS:000278404300036
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: A gold(III) porphyrin complex with antitumor properties targets the Wnt/β-catenin pathway
Title | A gold(III) porphyrin complex with antitumor properties targets the Wnt/β-catenin pathway | ||||||||
---|---|---|---|---|---|---|---|---|---|
Authors | |||||||||
Issue Date | 2010 | ||||||||
Publisher | American Association for Cancer Research. The Journal's web site is located at http://cancerres.aacrjournals.org/ | ||||||||
Citation | Cancer Research, 2010, v. 70 n. 1, p. 329-337 How to Cite? | ||||||||
Abstract | Gold(III) complexes have shown promise as antitumor agents, but their clinical usefulness has been limited by their poor stability under physiological conditions. A novel gold(III) porphyrin complex [5-hydroxyphenyl-10,15,20- triphenylporphyrinato gold(III) chloride (gold-2a)] with improved aqueous stability showed 100-fold to 3,000-fold higher cytotoxicity than platinum-based cisplatin and IC50 values in the nanomolar range in a panel of human breast cancer cell lines. Intraductal injections of gold-2a significantly suppressed mammary tumor growth in nude mice. These effects are attributed, in part, to attenuation of Wnt/β-catenin signaling through inhibition of class I histone deacetylase (HDAC) activity. These data, in combination with computer modeling, suggest that gold-2a may represent a promising class of anticancer HDAC inhibitor preferentially targeting tumor cells with aberrant Wnt/β-catenin signaling. ©2010 AACR. | ||||||||
Persistent Identifier | http://hdl.handle.net/10722/65442 | ||||||||
ISSN | 2023 Impact Factor: 12.5 2023 SCImago Journal Rankings: 3.468 | ||||||||
ISI Accession Number ID |
Funding Information: Grants from Seeding Funds for Basic Research of the University of Hong Kong (Y. Wang), Hong Kong Research Grant Council grants HKU 777908M (Y. Wang) and HKU 779707M (A. Xu), and the Area of Excellent Scheme AoE/P-10-01 established under University Grants Committee HKSAR (C. Che). | ||||||||
References | |||||||||
Grants |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chow, KHM | en_HK |
dc.contributor.author | Sun, RWY | en_HK |
dc.contributor.author | Lam, JBB | en_HK |
dc.contributor.author | Li, CKL | en_HK |
dc.contributor.author | Xu, A | en_HK |
dc.contributor.author | Ma, DL | en_HK |
dc.contributor.author | Abagyan, R | en_HK |
dc.contributor.author | Wang, Y | en_HK |
dc.contributor.author | Che, CM | en_HK |
dc.date.accessioned | 2010-08-06T02:36:21Z | - |
dc.date.available | 2010-08-06T02:36:21Z | - |
dc.date.issued | 2010 | en_HK |
dc.identifier.citation | Cancer Research, 2010, v. 70 n. 1, p. 329-337 | en_HK |
dc.identifier.issn | 0008-5472 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/65442 | - |
dc.description.abstract | Gold(III) complexes have shown promise as antitumor agents, but their clinical usefulness has been limited by their poor stability under physiological conditions. A novel gold(III) porphyrin complex [5-hydroxyphenyl-10,15,20- triphenylporphyrinato gold(III) chloride (gold-2a)] with improved aqueous stability showed 100-fold to 3,000-fold higher cytotoxicity than platinum-based cisplatin and IC50 values in the nanomolar range in a panel of human breast cancer cell lines. Intraductal injections of gold-2a significantly suppressed mammary tumor growth in nude mice. These effects are attributed, in part, to attenuation of Wnt/β-catenin signaling through inhibition of class I histone deacetylase (HDAC) activity. These data, in combination with computer modeling, suggest that gold-2a may represent a promising class of anticancer HDAC inhibitor preferentially targeting tumor cells with aberrant Wnt/β-catenin signaling. ©2010 AACR. | en_HK |
dc.language | eng | - |
dc.publisher | American Association for Cancer Research. The Journal's web site is located at http://cancerres.aacrjournals.org/ | en_HK |
dc.relation.ispartof | Cancer Research | en_HK |
dc.subject.mesh | Antineoplastic Agents - pharmacology | - |
dc.subject.mesh | Gold Compounds - pharmacology | - |
dc.subject.mesh | Mammary Neoplasms, Experimental - drug therapy | - |
dc.subject.mesh | Metalloporphyrins - pharmacology | - |
dc.subject.mesh | Signal Transduction - drug effects | - |
dc.title | A gold(III) porphyrin complex with antitumor properties targets the Wnt/β-catenin pathway | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0008-5472&volume=70&issue=1&spage=329&epage=337&date=2010&atitle=A+gold(III)+porphyrin+complex+with+antitumor+properties+targets+the+Wnt/beta-catenin+pathway | - |
dc.identifier.email | Sun, RWY: rwysun@hku.hk | en_HK |
dc.identifier.email | Xu, A: amxu@hkucc.hku.hk | en_HK |
dc.identifier.email | Ma, DL: edmondma@hku.hk | en_HK |
dc.identifier.email | Wang, Y: yuwanghk@hku.hk | en_HK |
dc.identifier.email | Che, CM: cmche@hku.hk | en_HK |
dc.identifier.authority | Sun, RWY=rp00781 | en_HK |
dc.identifier.authority | Xu, A=rp00485 | en_HK |
dc.identifier.authority | Ma, DL=rp00760 | en_HK |
dc.identifier.authority | Wang, Y=rp00239 | en_HK |
dc.identifier.authority | Che, CM=rp00670 | en_HK |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.doi | 10.1158/0008-5472.CAN-09-3324 | en_HK |
dc.identifier.pmid | 19996284 | - |
dc.identifier.scopus | eid_2-s2.0-75149132744 | en_HK |
dc.identifier.hkuros | 173047 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-75149132744&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 70 | en_HK |
dc.identifier.issue | 1 | en_HK |
dc.identifier.spage | 329 | en_HK |
dc.identifier.epage | 337 | en_HK |
dc.identifier.isi | WOS:000278404300036 | - |
dc.publisher.place | United States | en_HK |
dc.relation.project | Molecular mechanisms underlying the hepato-protective functions of the fat cell-derived hormone adiponectin: potential roles of uncoupling protein 2 | - |
dc.relation.project | APPL1 as a novel modulator of endothelial nitric oxide production and endothelium-dependent vasodilation | - |
dc.identifier.scopusauthorid | Chow, KHM=26430472800 | en_HK |
dc.identifier.scopusauthorid | Sun, RWY=26325835800 | en_HK |
dc.identifier.scopusauthorid | Lam, JBB=24448474900 | en_HK |
dc.identifier.scopusauthorid | Li, CKL=14037827700 | en_HK |
dc.identifier.scopusauthorid | Xu, A=7202655409 | en_HK |
dc.identifier.scopusauthorid | Ma, DL=7402075538 | en_HK |
dc.identifier.scopusauthorid | Abagyan, R=7006710879 | en_HK |
dc.identifier.scopusauthorid | Wang, Y=34973733700 | en_HK |
dc.identifier.scopusauthorid | Che, CM=7102442791 | en_HK |
dc.identifier.issnl | 0008-5472 | - |